CePRO: Usability and Satisfaction With an Electronic Survey Administration Application in General Population

Sponsor
Massachusetts General Hospital (Other)
Overall Status
Unknown status
CT.gov ID
NCT04102384
Collaborator
Cenduit LLC (Industry)
30
1
2
4.9
6.1

Study Details

Study Description

Brief Summary

The goal of the study is to assess the usability and satisfaction of an electronic patient reported outcomes (e-PRO) mobile application. The secondary aim is to assess and compare response rates between two study groups (e-PRO group vs REDCap survey group). A potential differentiating factor between delivering surveys via smart phone and other electronic modes of delivery is the perceived advantage of being able to conveniently complete survey questionnaires at any time and any location. This could help address certain limitations of the quantitative survey method such as recall bias. Furthermore, the portability, connectivity and ubiquity of smartphones may reduce the amount of training or instructions required for users to complete a survey questionnaire on a smartphone.

Condition or Disease Intervention/Treatment Phase
  • Other: e-PRO App
N/A

Detailed Description

Patient-reported outcomes (PROs) are vital to understanding the impact of a medical condition and treatment from the participant's perspective. However, the collection of data can be inconsistent in both administration and completion due to the method of delivery. Thus, careful consideration of the data collection mode is needed to ensure the quality of the data. The method of delivery has been shown to have a direct effect on the survey response rates thereby ensuring the validity of the data analyses and results. Previous studies have demonstrated an increase in Web-based survey response rates as compared to paper-based survey response rates. Novel methods of collecting PROs may help to streamline both the process and collection of PROs during clinical trials.

A potential differentiating factor between delivering surveys via smart phone and other electronic modes of delivery is the perceived advantage of being able to conveniently complete survey questionnaires at any time and any location. This could help address certain limitations of the quantitative survey method such as recall bias. Furthermore, the portability, connectivity and ubiquity of smartphones may reduce the amount of training or instructions required for users to complete a survey questionnaire on a smartphone. For researchers, this type of survey delivery method may offer the benefits of a wider target audience and reduce research implementation costs. The e-PRO app is designed to further facilitate the delivery of PRO instruments in a convenient manner to participants. Through its computing capability, and user-friendly interface, the e-PRO app can collect data and implement complex scoring requirements, thus supporting the delivery of self-administered survey questionnaires. The goal of this two-arm randomized controlled pilot is to explore the usability and satisfaction with a novel e-PRO app.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
30 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Intervention- one group will use a smartphone application to fill out surveys while the other group fills out surveys via an emailed embedded link.Intervention- one group will use a smartphone application to fill out surveys while the other group fills out surveys via an emailed embedded link.
Masking:
Single (Participant)
Masking Description:
Participants will not know which group (smart phone or embedded link) is the intervention vs. control group.
Primary Purpose:
Other
Official Title:
Usability and Satisfaction With an Electronic Survey Administration Application in General Population
Anticipated Study Start Date :
Oct 1, 2019
Anticipated Primary Completion Date :
Jan 30, 2020
Anticipated Study Completion Date :
Feb 28, 2020

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Control Group

Participants will be enrolled for a period of 4 weeks. At baseline, we will collect demographic information on participants. During the study, participants will be asked to fill out daily and weekly surveys using an electronically link sent via email. Additionally, participants will be asked to fill out one survey once a week during the study period.

Experimental: Intervention Group

Participants will be enrolled for a period of 4 weeks. At baseline, we will collect demographic information on participants. During the study, participants will be asked to fill out daily and weekly surveys using the e-PRO app. Additionally, participants will be asked to fill out one survey once a week during the study period. A subgroup of these participants will be asked to complete an additional interview to collect more information on their experiences using the mobile app.

Other: e-PRO App
The e-PRO app is designed to further facilitate the delivery of PRO instruments in a convenient manner to participants. Through its computing capability, and user-friendly interface, the e-PRO app can collect data and implement complex scoring requirements, thus supporting the delivery of self-administered survey questionnaires.

Outcome Measures

Primary Outcome Measures

  1. Usability of e-PRO vs. emailed link: survey [At close-out]

    A survey will be administered to compare groups on their experiences with the survey-method administration (Investigator developed survey). The following components will be taken into account: acceptability-- participant satisfaction with various aspects of the solution (e.g. content, complexity, comfort, delivery, and credibility). Adoption-- participants' intention to try; perceived barriers and facilitators for uptake. Appropriateness-- participant's perceived relevance to need; suitability to daily patient workflow. Feasibility-- suitability for using daily, weekly etc. This survey is not a scored survey.

Secondary Outcome Measures

  1. Survey response rate e-PRO vs emailed link [At close-out]

    Response rate will be tracked on a weekly basis from the e-PRO system and the REDCap embedded email link to compare response rate between the control and intervention group. The AAOPR (2006) recommendation for RR formula will be used to calculate the RR. This is the number of completed surveys (completed and partially completed) divided by the number of completed surveys (completed and partially completed) plus the number of all non-completed surveys (sent to a potential participant but not completed because of incorrect e-mail address, incorrect mailing address, or other reasons).

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Healthy participants over the age of 18-65 years as assessed by the Self-Rated Health Measure.

  • Fluency in English language to be able to read, understand study procedures and complete surveys administered during the study.

  • Willing to travel to the downtown Boston area to participate in up to two study visits.

  • Willing to participate in the research study and sign informed consent.

Exclusion Criteria:
  • Participants with a "fair" or "poor" rating on the Self-Rated Health Measure.

  • Participants with EU citizenship or permanent residency

  • Participants with severe cognitive, vision, hearing, or speech problems that may prevent them from answering surveys

  • Participants with serious psychiatric conditions (moderate or major depressive disorder that may impair their ability to complete surveys

  • Participants with any terminal illness (e.g. cancers)

  • Patients with implantable devices, pacemakers or body worn electronic medical devices

Contacts and Locations

Locations

Site City State Country Postal Code
1 Partners Healthcare Boston Massachusetts United States 02114

Sponsors and Collaborators

  • Massachusetts General Hospital
  • Cenduit LLC

Investigators

  • Principal Investigator: Ramya S Palacholla, MD, MPH, Partners HealthCare

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ramya Sita Palacholla, MD, MPH, Partners Healthcare, Massachusetts General Hospital
ClinicalTrials.gov Identifier:
NCT04102384
Other Study ID Numbers:
  • 2019P002811
First Posted:
Sep 25, 2019
Last Update Posted:
Sep 30, 2019
Last Verified:
Sep 1, 2019
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Ramya Sita Palacholla, MD, MPH, Partners Healthcare, Massachusetts General Hospital

Study Results

No Results Posted as of Sep 30, 2019